Abbott: New Study Shows Spinal Cord Stimulation Can Reduce, Stabilize Opioid Use Among Chronic Pain Patients

New research has found spinal cord stimulation (SCS) therapy can be key to reducing or stabilizing the use of opioids in patients battling chronic pain.


In a new study, researchers examined opioid usage data from more than 5,400 patients both prior to and after receiving an SCS system implant. In an SCS system, an implanted device similar to a pacemaker delivers low levels of electrical energy to nerve fibers, interrupting pain signals as they travel to the brain to reduce the sensation of pain. Researchers have found that average daily opioid use declined or stabilized for patients receiving a successful SCS system compared to patient use of opioids prior to an implant.

In addition, while opioid usage was not different for the two groups at time of implant, patients who underwent a successful SCS implant had significantly lower opioid use one year after their implant. Patients who had their SCS system removed saw their opioid use increase again over time.

The study, which the researchers believe makes a compelling case for considering SCS therapy earlier in the chronic pain care continuum, were presented at the 2017 North American Neuromodulation Society (NANS) annual meeting by Ashwini Sharan, M.D., director of Functional and Epilepsy Surgery at Vickie and Jack Farber Institute for Neuroscience at Jefferson and president of NANS. The study was sponsored by Abbott(No. 14 on the DiversityInc Top 50 Companies list), a global leader in the development and manufacture of SCS systems and therapy options, such as the company’s proprietary BurstDR stimulation.

Currently, more than 2.1 million people in the U.S. suffer from substance abuse related to opioid pain relievers, while worldwide an estimated 15.5 million people are now classified as opioid dependent. Chronic pain is often a driver of opioid use as patients seek relief and improvements to their quality of life. Fortunately for patients, SCS therapy has been clinically proven to offer meaningful relief to patients suffering from chronic pain.

“Given the epidemic of opioid addiction and abuse, these findings are important and confirm that spinal cord stimulation therapy can offer strong benefits for patients struggling with chronic pain,” said Sharan. “Based on these results, we concluded it may be possible to improve outcomes by offering our patients spinal cord stimulation earlier, before opioid dependence and addiction can occur.”

About the Study:

For their analysis, the research team assessed private and Medicare insurance claims data from 5,476 patients who received an SCS system to treat chronic pain associated with a host of conditions (excluding pain related to cancer). The data were collected between January 2010 and December 2014.

The data confirmed that many patients are often prescribed increasing dosages of opioids prior to receiving an SCS system. The researchers also found:

  • SCS therapy is effective for patients at any level of opioid usage prior to implantation.
  • Opioid use declined or stabilized in 70 percent of patients who received an SCS system.
  • Among patients who had their SCS system explanted, opioid use was higher at one year compared to those who continued with SCS therapy.

The researchers further suggested patient outcomes could be improved if SCS were implanted earlier in recognition of the clinical practice to provide increasing dosages of opioids over time. These conclusions help build upon prior research, such as results of a large multi-center randomized controlled trial in patients with failed back surgery syndrome (FBSS) that showed trends in opioid reduction or cessation among SCS patients. In addition, new technologies released in the U.S. in 2015 and 2016 hold promise to improve outcomes further and may reduce common complications resulting in explant such as the undesired changes in paresthesia, issues with charging, pain at the implantable pulse generator (IPG) site, and loss of pain relief.

“As our society has been seeking ways to stem opioid abuse and addition, our company offers treatment options that can reduce their exposure to opioid medication,” said Allen Burton, M.D., medical director of neuromodulation at Abbott. “Data like these are critical to helping us demonstrate that spinal cord stimulation can reduce exposure to opioids while giving patients comprehensive pain relief.”

Latest News

Rep. Jahana Hayes (D-Conn.)

Rep. Jahana Hayes Attacked in Racist Campaign Town Hall; 1 in 4 Americans Unemployed According to New Data from Axios; and More

Racist trolls interrupt Zoom town hall hosted by Jahana Hayes, Connecticut’s first Black congresswoman. “I am not OK,” wrote Rep. Jahana Hayes (D-Conn.) in a moving post describing a violent attack that took place at one of her recent campaign events. Ten minutes into the Zoom town hall for one…

reproductive, benefits, workplace

The Importance of Reproductive Benefits in the Workplace

With President Trump’s nomination of Amy Coney Barrett to take the late Justice Ruth Bader Ginsburg’s seat, the issue of reproductive rights has again become a hot button topic. While Ginsburg repeatedly voted against restrictions on birth control and abortion access, the historically conservative Barrett is expected to tip the…

domestic, violence, awareness

October: Domestic Violence Awareness Month Resources

National Domestic Violence Awareness Month takes place in October to raise awareness about this critical social and public health issue. One out of every four women and one out of every 10 men will experience sexual violence, physical violence and/or stalking by an intimate partner in their lifetime according to…

Thousands of Vets Missing Out on Key Benefits; Sesame Street Tackles Racism; and More

Thousands of veterans with “less-than-honorable” discharges missing out on government benefits; facing unnecessary challenges in employment. Being dishonorably discharged from the military can wreak havoc on a veteran’s career. Whether it was the result of alcohol or drug abuse, insubordination, fighting or being LGBTQ+ or disabled (areas that were not…

Comcast Offers Thousands of Grants, Equipment, Marketing and Tech Resources to Small Businesses Hardest Hit by COVID

Originally published on Comcast.com Comcast Corporation (NASDAQ: CMCSA) today launched Comcast RISE, an initiative created to help strengthen and empower small businesses hard hit by COVID-19. The Comcast RISE program will help thousands of small businesses over the next three years. The multi-faceted program offers grants, marketing and technology upgrades,…

Cigna

Keith Barnes Named Market President for Cigna’s Commercial Business in North Texas and Oklahoma

Originally published on Cigna.com Cigna (NYSE:CI) has named Keith Barnes as market president for its commercial health care and related benefits plans in North Texas and Oklahoma. In this role, his responsibilities include driving market growth by creating customer value and ensuring that the local market strategy, product and network offerings meet evolving customer and…

Southern Company Signs the Hispanic Promise

Earlier this month, Southern Company signed the Hispanic Promise, an initiative of the We Are All Human Foundation. The Promise is the first-of-its-kind national pledge to hire, promote, retain and celebrate Hispanics in the workplace. Launched at the World Economic Forum in 2019, the Hispanic Promise is a non-legally binding sign…